两个基于柔性双苯并咪唑配体的锌配位聚合物的合成、晶体结构和荧光性质

以1,4-双(2-甲基苯并咪唑-1-亚甲基)苯(bmb)和2个芳香多羧酸1,2,4,5-均苯四酸(H4btec)、4-(3,4-二羧基苯甲酰)邻苯二甲酸(H4dcbp)为配体,在水热条件下合成了2个锌配位聚合物{[Zn(bmb)_(0.5)(btec)_(0.5)(H_2O)]·H_2O}_n(1)和{[Zn_2(bmb)_2(dcbp)]·5H_2O}_n(2),并用X射线单晶衍射、红外光谱、元素分析和粉末衍射对其结构进行了表征。晶体结构测试表明2个聚合物均为复杂的三维框架结构,配体bmb在2个配合物中均为μ_2-η~1∶η~1的配位模式。此外还研究了2个配合物的荧光性质和热稳定性。     

由芳香羧酸构筑的系列Ni(Ⅱ)配合物的合成、结构及光电性能

采用水热法设计合成了6个基于芳香羧酸的Ni(Ⅱ)配合物:[Ni(pz)_4(H_2O)_2]·2H_2btc·H_2O(1),{[Ni_2(pz)_8(btec)]·4H_2O}n(2),{[Ni (H_2btec)(phen)]·2H_2O}n(3),[Ni (Hbdc)_2(pz)_4](4),{[Ni_3(bdc)_3(pz)_(12)]·2H_2O}n(5)和[Ni(bdc)(pz)_2(H_2O)]n(6)(pz=吡唑,H_3btc=1,3,5-苯三甲酸,H_4btec=1,2,4,5-苯四甲酸,phen=1,10-邻菲罗啉,H_2bdc=邻苯二甲酸).通过单晶X射线衍射、红外光谱(IR)、紫外-可见-近红外吸收光谱、元素分析、粉末X射线衍射(XRD)和表面光电压光谱(SPS)对其进行了结构和性质表征. 6个配合物的金属Ni(Ⅱ)中心呈五或六配位.配合物1和4具有完全由氢键网联成的2D超分子结构;配合物2和3是通过采取单齿/桥双齿配位模式的btec4-构筑的2D配位骨架结构;配合物5和6是由采取单齿/螯合双齿配位模式的bdc2-构筑的1D配位骨架结构,并由氢键连接成2D结构. 6个配合物在紫外和可见光诱导下均呈现出一定的光-电转换性能.当对配合物施加外加电场时,6个配合物的光电响应因配合物组成、结构键连方式以及配体种类的不同而呈现规律性变化.     

两个三维锌(Ⅱ)配位聚合物的晶体结构及荧光性质

通过水热合成的方法制备了2个Zn(Ⅱ)配位聚合物{[Zn_(1.5)(dbim)_(1.5)(btc)]·6H_2O}_n(1)和{[Zn(dbim)_(0.5)(btec)_(0.5)(H_2O)]·H_2O}_n(2)(dbim=1-(4-((2,6-dimethyl-2H-benzo[d]imidazol-3(3H)-yl)methyl)benzyl)-2,7-dihydro-2,5-dimethyl~(-1)H-benzo[d]imidazole,H_3btc=1,3,5-苯三酸,H_4btec=1,2,4,5-苯四甲酸)。结构分析表明配合物1是一个三节点(3,4,4)-连接的网络,拓扑符号为(5~2·6·7·8~2)(5~2·6)(5~2·6~2·8~2)。配合物2是一个(3,4)-连接的网络,拓扑符号为(8~3)(8~5·10)。配合物1和2的固态荧光与配体dbim不同。     

由2,3-二羟基-对苯二甲酸配体构筑的锰(Ⅱ)和镉(Ⅱ)配位聚合物的合成、晶体结构、荧光及催化性质（英文）

采用水热方法,用2,3-二羟基-对苯二甲酸配体(H_4DTA)和2,2′-联吡啶(bipy)分别与Mn Cl_2·4H_2O和Cd Cl_2·H_2O反应,合成了2个三维配位聚合物[M(μ_4-H_2DTA)(bipy)]_n(M=Mn (1)、Cd (2)),并对其结构、荧光和催化性质进行了研究。单晶结构分析结果表明2个配合物同构,均属于正交晶系,Pnna空间群。配合物1和2都具有三维框架结构。另外,研究了2个配合物的荧光和催化性质。研究表明,配合物1在硅腈化反应中表现出较高的催化活性。     

两个基于4-甲基-1,2,3-噻二唑-5-甲酸构筑的铜、锌配位聚合物的合成、晶体结构及性质

合成了两个新型配位聚合物[Cu_2(OH)(H_2O)(L)_3(bpp)]_n(1),[Zn(L)_2(H_2O)(bipy)]_n(2)(HL=C_4H_4N_2O_2S,4-甲基-1,2,3-噻二唑-5-甲酸; bpp=1,3-双(4-吡啶基)-丙烷; bipy=4,4’-联吡啶),用元素分析、红外光谱、热重分析和单晶X-射线衍射对产物进行了表征和结构测定.配合物1是双核结构,中心金属离子Cu~(2+)的配位数均为五,构成略为变形的三角双锥体;配合物2的中心金属离子Zn~(2+)的配位构型是扭曲的三角双锥结构.配合物1通过氢键形成了二维结构,配合物2通过分子间氢键和π-π堆积作用形成了三维结构.用荧光光谱法研究了配体和配合物与DNA之间的相互作用.     

由2-(4''-羧基苯基)咪唑-4,5-二羧酸构筑的过渡金属配位聚合物的合成、结构及性质

在溶剂热条件下,由2-(4′-羧基苯基)咪唑-4,5-二羧酸(H_4L,C_(12)H_8N_2O_6),合成了4个配位聚合物{[M(H_3L)_2]·2H_2O}_n(M=Zn(1),Cd(2),Co(3)),[Cd(H_2L)(H_2O)]_n(4)。用元素分析、红外光谱、热重分析和单晶X射线衍射对配合物进行了表征和结构分析。结构分析结果表明:1～3是异质同晶。配体失去1个质子以H_3L~-的形式通过单齿和N,O-双齿螯合的配位模式与中心金属离子配位,构成一个略有变形的八面体结构。对于配合物4来说,配体失去2个质子以H_2L~(2-)的形式分别通过单齿和N,O-双齿螯合的配位方式与Cd~(2+)配位,中心离子采取扭曲的七配位五角双锥配位模式,并且通过配体苯环上羧基氧原子的双齿桥联作用连接2个中心离子,形成四元环的双核结构;同时呈现双节点(3,6)-连接的二维拓扑网络(4.4.4)(4.4.4.4.4.4.5.6.6.6.6.6)。测定了产物的固体荧光光谱;用EtBr荧光探针法研究了配体及配合物与ct-DNA的相互作用。     

两个二维层状4-双(咪唑基-1-甲基)-苯钴和镍配位聚合物的合成与表征

以1,4-双(咪唑基-1-甲基)-苯(bix)为配体,间苯二甲酸(IPA)为辅助配体,合成制备了两种新型同构配位聚合物:{[Ni(bix)(IPA)(H_2O)]}_n(1)和{[Co(bix)(IPA)(H_2O)]}_n(2)。单晶结构表明,此两个配合物均形成二维层状空间结构,金属原子均为六配位八面体结构,赤道平面上四个配位原子来自间苯二甲酸和配位水分子,轴向两个配位原子为bix配体的咪唑环上的N原子。金属原子通过配体连接形成四连接的二维4(4).6(2)方格层状结构。     

过渡金属离子与3-氟邻苯二甲酸和1,10-邻菲啰啉配合物的合成、结构及性质

过渡金属离子与3-氟邻苯二甲酸(H2Fpht)、1,10-邻菲啰啉(phen)通过水热反应得到了5个配合物:[M(Fpht)(phen)(H2O)3]·H2O(M=Ni 1,Co 2),[Cu(Fpht)(phen)(H2O)]·H2O(3),[M(Fpht)(phen)(H2O)]·H2O(M=Zn 4,Cd 5)。通过X-射线单晶衍射分析、元素分析、红外分析、荧光分析以及差热-热重分析对配合物进行了表征。配合物1和2为单核分子,中心离子Ni(Ⅱ)和Co(Ⅱ)与3-氟邻苯二甲酸根的1个氧原子,1,10-邻菲啰啉的2个氮原子以及3个配位水分子的3个氧原子配位,形成六配位的扭曲八面体构型。配合物3为Z字形一维链状结构。中心Cu(Ⅱ)离子与2个3-氟邻苯二甲酸根的2个氧原子,1个1,10-邻菲啰啉的2个氮原子以及水分子的1个氧原子配位,形成四方锥构型。配合物4和5具有相似的一维螺旋结构,中心Zn(Ⅱ)和Cd(Ⅱ)离子与2个3-氟邻苯二甲酸根的3个氧原子、1,10-邻菲啰啉的2个氮原子以及水分子中的1个氧原子配位,形成扭曲的八面体构型。     

含咪唑基配体镉配位聚合物的合成、结构及荧光性质

利用柔性含咪唑基配体1,3,5-三(咪唑-1-甲基)苯(L)与硫酸镉在溶剂热条件下反应,通过反应条件控制得到了2个配位聚合物{[Cd(L)(EG)0.5(H2O)(SO4)]·EG·H2O}n(1)和[Cd(L)(EG)(SO4)]n(2)(EG=乙二醇)。并利用元素分析、红外光谱、X射线单晶衍射等方法对其进行了表征。配合物1中配体L连接Cd(Ⅱ)形成一维链状结构,而配合物2中配体L与Cd(Ⅱ)配位形成二维网状结构,并进一步通过硫酸根桥联形成三维结构。有趣的是,EG分子在配合物1中连接链内的2个Cd(Ⅱ),而在配合物2中作为端基与1个Cd(Ⅱ)配位,硫酸根离子在1中作为端基配位,而在2中则以桥联方式连接2个Cd(Ⅱ)。研究了配合物的荧光性质及其热稳定性。     

两个基于π-共轭二羧酸构筑的配位聚合物的晶体结构、磁性及光催化性能

在水热条件下,利用具有π共轭体系的二羧酸H2L与金属盐进行配位反应得到2个新颖的配位聚合物:{[Mn_2(L)_2(H_2O)_5]·2H_2O}n(1)和[Cd(L)(H_2O)_2]n(2),并通过元素分析、红外光谱、粉末X射线衍射分析、单晶X射线衍射等对其结构进行了表征。结构分析表明,配合物1是具有一维{Mn3(COO)_2}链的二维层状结构,而配合物2中镉离子与L2-配体中的羧基氧螯合配位,最终得到一维链状结构。配合物1和2都通过结构单元之间的氢键作用,最终形成三维超分子结构。此外,还研究了配合物1的磁性和配合物2的光催化活性。     

3-(Carbazol-2-yl)- and 3-(Carbazol-3-yl)-dl-alanines

A facile transformation of 2- and 3-methylcarbazoles into 3-(carbazol-2-yl)-and 3-(carbazol-3-yl)-dl-alanines compounds is described.     

Synthesis of 6-Methyl-4-(1-methyl-2-buten-1-yl)-2-(2-cyclohexen-1-yl)- and 6-Methyl-4-(1-methyl-2-buten-1-yl)-2-(1-cyclohexen-1-yl)anilines

Alkenylation of 6-methyl-2-(2-cyclohexen-1-yl)- and 2-(1-cyclohexen-1-yl)anilines with piperylene in the presence of AlCl₃ and transformation of the resulting cyclohexenylanilines into carbazole structures were studied.__________Translated from Zhurnal Prikladnoi Khimii, Vol. 78, No. 3, 2005, pp. 441–443.Original Russian Text Copyright © 2005 by Gataullin, Ishberdina, Sotnikov, Abdrakhmanov.     

Synthesis of σ-(o-carboran-9-yl)- and σ-(m-carboran-9-yl)-π-cyclopentadienyldicarbonyliron and their rearrangement in reactions with bromine to π-(o-carboran-9-yl)cyclopentadienyl- and π-(m-carboran-9-yl)cyclopentadienyl-dicarbonylironbromides,respectively

9-o- and 9-m-carboranylcarboxylic acids were used to synthesize σ-(o-carboran-9-yl)- and σ-(m-carboran-9-yl)-π-cyclopentadienyldicarbonyliron. The latter complexes, in reactions with bromine, undergo rearrangement with the cleavage of the BFe σ-bond, involving migration of the 9-o- and 9-m-carboranyl groups into the cyclopentadienyl ring, to give π-(o-carboran-9-yl)cyclopentadienyl- and π-(m-carboran-9-yl)cyclopentadienyl-dicarbonyliron bromides, respectively. A simple method to obtain these acids by the oxidation of 9-alkyl-o- and 9-alkyl-m-carboranes with CrO₃ in CH₃COOH has been found.     

1-(Fluoren-2-yl)-2-(2-azafluoren-3-yl)ethene and 1-(fluoren-2-yl)-2-(2H,2-methylindeno[2,3-c]pyridine)ethene

Condensation of 3-methyl-2-azafluorene with 2-formylfluorene results in the formation of a compound containing a polyconjugated system and two acidic CH centers, namely, 1-(fluoren-2-yl)-2-(2-azafluoren-3-yl)ethene. The conversions of this compound upon treatment with alkali have been studied by electronic absorption spectroscopy. The methyl iodide derivative of this base was used as an intermediate in the preparation of a pseudo-azulene, 1-(fluoren-2-yl)-2-(2H, 2-methylindeno[2,3-c]pyridine)ethene.Translated from Khimiya Geterotsiklicheskikh Soedinenii No. 5, pp. 657–659, May, 1987.     

Synthesis and Properties of 1-(Alkylsulfanyl)-3-(morpholin-4-yl)propan-2-yl Arylcarbamates and Arylcarbamothioates

Russian Journal of Organic Chemistry - New arylcarbamates and arylcarbamothioates were synthesized by reactions of 1-(alkylsulfanyl)-3-(morpholin-4-yl)propan-2-ols with aryl isocyanates and aryl...     

2-(2,4-二氟苯基)-1-(4-烃基派嗪-1-基)-3-(1,2,4-三唑-1-基)-2-丙醇类化合物的合成及抗真菌活性

近20年来,真菌感染特别是深部真菌感染日益引起人们的广泛关注[1]。三唑类抗真菌药物对真菌的选择性较高,代谢稳定,体内动态、安全性都较好,已成为目前抗真菌药物研究开发的重点[2]。三唑类抗真菌药物是细胞色素P450 14α 去甲基酶的抑制剂,可影响该酶所催化的真菌麦角甾醇的生物合成,导致真菌细胞膜破损而死亡[3,4]。1998年,SynPhar实验室及Taiho制药公司[5]研制开发的化合物Syn 2869采用了取代哌嗪作为侧链。体外实验表明,该化合物抗菌谱广,对多种念珠菌、隐球菌及曲莓菌均有效,体内实验中,与目前临床上治疗真菌感染的主要用药伊曲…     

Crystal Structure and Theoretical Energy Gap of 2-(2-((4-(Pyridin-2-yl)pyrimidin-2-yl)disulfanyl)pyrimidin-4-yl) pyridinium Hexafluorophosphate

The crystal structure of 2-(2-((4-(pyridin-2-yl)pyrimidin-2-yl)disulfanyl)pyrimidin-4-yl)pyridinium hexafluorophosphate was obtained by X-ray single-crystal diffraction. This molecule crystallizes in monoclinic P2/c space group with a=6.219(1), b=13.103(2), c=13.059(2) ?, β=97.567(2)°, Z=2, the final R=0.0525 and w R=0.1434. The title compound was prepared successfully from 1,2-bis(4-(pyridin-3-yl)pyrimidin-2-yl)disulfane(BPPD). TD-DFT computational studies on energy gaps and UV-Vis spectra of BPPD and the title compound have been carried out for comparisons. The resultant HOMO-LUMO gap of the BPPD compound is 4.45 e V, while that for the corresponding hexafluorophosphate salt is much smaller at 2.46 e V, which are in agreement with their UV-Vis absorptions.     

5-(N-Arylnortropan-3-yl)- and 5-(N-Arylpiperidin-4-yl)-2,4-diaminopyrimidines. Novel Inhibitors of Dihydrofolate Reductase

Based on a computer-assisted analysis of the three-dimensional structure of the binary complex of E.coli dihydrofolate reductase (DHFR) with methotrexate, 5-(N-arylnortropan-3-yl)- and 5-(N-arylpiperidin-4-yl)-2,4-diaminopyrimidines 2 and 4 were designed as inhibitors of DHFR. Syntheses of the designed compounds have been carried out. The most potent compound 2a inhibited E. coli DHFR with K_i = 0.49.10^?9M. The activities within the series of compounds synthesized could be rationalized by molecular-modelling experiments which served as the basis of this work. Several compounds within the presented series exhibit antimalarial activities in vitro and in vivo.     

Synthesis of Geminally Activated 4-(Furan-2-yl)- and 4-(Thiophen-2-yl)-1-nitrobuta-1,3-dienes

The condensation of 3-(furan-2-yl)- and 3-(thiophen-2-yl)prop-2-enals with nitro-substituted CH acids, namely ethyl nitroacetate, nitroacetone, nitroacetophenone, and nitroacetonitrile, afforded a series of geminally activated nitro dienes, 4-(furan-2-yl)- and 4-(thiophen-2-yl)-1-nitrobuta-1,3-dienes. The product structure was confirmed by NMR and IR spectroscopy.